We aimed to investigate whether TRF regimen has beneficial effects on reproductive and metabolic manifestations in an animal model of PCOS induced by letrozole, a nonsteroidal aromatase inhibitor. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.